RedHill Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	2.87	1.88	5.57	19.97	29.47	29.3
Short-Term Investments	-	2.74	-	0.02	8.53	0.02
Trading Asset Securities	-	-	-	-	-	0.48
Cash & Short-Term Investments	2.87	4.62	5.57	19.98	38	29.79
Cash Growth	-60.62%	-17.09%	-72.13%	-47.42%	27.56%	-37.77%
Accounts Receivable	5.35	2.54	2.59	34.52	31.68	28.66
Other Receivables	-	0.33	0.69	0.83	0.85	0.63
Receivables	5.35	2.87	3.29	35.35	32.52	29.29
Inventory	3.17	3.65	4.39	11.01	14.81	6.53
Prepaid Expenses	1.01	0.69	0.8	2.52	3.18	2.34
Restricted Cash	0.16	-	0.79	16	-	-
Other Current Assets	-	0.08	1.31	1.03	0.63	2.54
Total Current Assets	12.56	11.91	16.14	85.9	89.15	70.5
Property, Plant & Equipment	0.29	0.44	1.18	7.19	4.22	5.7
Other Intangible Assets	5.53	5.55	5.58	65.63	71.64	87.88
Other Long-Term Assets	-	0.15	0.15	0.15	16.17	16.16
Total Assets	18.38	18.04	23.05	158.87	181.19	180.24
Accounts Payable	0.84	1.17	3.28	4.23	11.66	11.55
Accrued Expenses	20.16	11.16	12.68	64.59	50.64	40.46
Current Portion of Long-Term Debt	-	-	-	115.22	-	-
Current Portion of Leases	0.21	0.35	0.72	1.03	1.62	1.71
Other Current Liabilities	1.08	9.54	3.31	12.39	17.55	19.51
Total Current Liabilities	22.29	22.22	19.98	197.45	81.47	73.24
Long-Term Debt	-	-	-	-	83.62	81.39
Long-Term Leases	-	0	0.46	6.44	2.57	3.81
Other Long-Term Liabilities	0.5	0.5	0.54	3.37	4.65	7.95
Total Liabilities	22.79	22.73	20.98	207.27	172.31	166.38
Common Stock	63.4	35.04	21.44	2.84	1.5	1.05
Additional Paid-In Capital	350.3	375.08	388.36	382.63	375.25	293.14
Retained Earnings	-418.12	-414.8	-407.74	-433.86	-367.87	-280.33
Shareholders' Equity	-4.41	-4.68	2.07	-48.4	8.88	13.86
Total Liabilities & Equity	18.38	18.04	23.05	158.87	181.19	180.24
Total Debt	0.21	0.36	1.17	122.69	87.81	86.9
Net Cash (Debt)	2.65	4.26	4.4	-102.71	-49.81	-57.11
Net Cash Growth	-60.53%	-3.07%	-	-	-	-
Net Cash Per Share	1.72	3.46	16.96	-1666.53	-1070.52	-1567.75
Filing Date Shares Outstanding	1.8	1.29	0.79	0.09	0.05	0.05
Total Common Shares Outstanding	1.8	1.29	0.79	0.09	0.05	0.04
Working Capital	-9.73	-10.31	-3.84	-111.55	7.68	-2.74
Book Value Per Share	-2.45	-3.63	2.63	-519.34	168.46	361.06
Tangible Book Value	-9.94	-10.23	-3.51	-114.03	-62.77	-74.02
Tangible Book Value Per Share	-5.51	-7.93	-4.46	-1223.51	-1191.42	-1927.57
Machinery	-	1.07	1.06	1.2	1.02	0.75
Leasehold Improvements	-	0.38	0.38	0.38	0.36	0.36

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q